# Lakewood-Amedex Biotherapeutics, Inc. (LABT): stock price, chart, support and resistance levels

> Source: IndicatorStack, https://indicatorstack.com/chart/LABT. Updated Nov 20, 2026, 7:55 PM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

## LABT at the Nov 20, 2026 close

Lakewood-Amedex Biotherapeutics (LABT) closed at $0.2449 on Nov 20, 2026, up 15.03% from the prior close of $0.2129, on roughly normal volume. It opened 9.1% higher and held that direction into the close.

LABT sits 0% of the way up its 52-week range of $0.1687 to $98.20. It trades 69.5% below its 50-day average. Over the past month the shares are down 50.0%. A typical day moves about 53.3% from high to low.

LiveChart’s stack bias on the 5-minute chart shows no clear direction. Compass, which reads the higher timeframes, has 0 of 2 timeframes up and 2 down. On the daily chart the bias turned bearish on Jul 13, 2026 at $2.73, and price has moved −91.0% since.

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.

## Key numbers

|  |  |
| --- | --- |
| Previous close | $0.2129 |
| Open | $0.2322 |
| Day range | $0.2210 to $0.3072 |
| 52-week range | $0.1687 to $98.20 |
| Volume | 57.67M (1.3× average) |
| 50-day average | $0.8024 |
| Average daily range | 53.3% |
| Average volume (20 days) | 45.03M |
| 1-week change | −13.3% |
| 1-month change | −50.0% |
| 3-month change | −88.5% |
| Market cap | $494K |
| Float | 283K shares |
| Sector | Healthcare |
| Industry | Biotechnology |

## LABT support and resistance levels

For the next session, measured from the Nov 20, 2026 close of $0.2449: resistance above, support below, nearest first.

| Side | Level | Price | From the close |
| --- | --- | --- | --- |
| Resistance | 20-bar high, 5-minute | $0.2615 | +6.8% |
| Resistance | Midpoint on Nov 20 | $0.2641 | +7.8% |
| Resistance | 20-day average | $0.2896 | +18.3% |
| Resistance | High on Nov 20 | $0.3072 | +25.4% |
| Support | 20-bar low, 5-minute | $0.2440 | −0.4% |
| Support | Prior session high | $0.2394 | −2.2% |
| Support | Low on Nov 20 | $0.2210 | −9.8% |
| Support | Prior session low | $0.2020 | −17.5% |
| Support | 52-week low | $0.1687 | −31.1% |

## LABT technical analysis: the stack’s read

As of Nov 20, 2026, 7:55 PM ET.

- Stack bias: No clear bias, waiting for agreement
  - Bigger picture (15m to daily): down
  - VWAP and SMA: down
  - Flow: down
  - Momentum: up
  - Trend strength: neutral
- Compass (higher timeframes): 15m and 1h down (15m ↘  1h ↓  2h ↘  4h ↓  D ↘). Below VWAP 0.2524 · below trend SMA · pressing yesterday’s high
- Yesterday’s high: $0.2394 (−2.2% from the close)
- Yesterday’s midpoint: $0.2207 (−9.9% from the close)
- Yesterday’s low: $0.2020 (−17.5% from the close)
- 20-bar resistance: $0.2615 (+6.8% from the close)
- 20-bar support: $0.2440 (−0.4% from the close)

LABT technical analysis for Nov 20, 2026 (close $0.2449; 5-minute read as of 7:55 PM ET): LiveChart’s 5-minute stack bias has no clear direction, Compass reads “15m and 1h down” across the 15-minute to daily charts, and the daily stack bias has been bearish since Jul 13, 2026. On the daily chart, RSI (14) is 35.8, rising (below 50) and the squeeze is off. On the 5-minute chart, Undertow reads hidden selling: price higher, flow lower; Coil reads momentum building down; Tripwire has shorts graded Avoid: sitting right on support at 0.2333.

## LABT trend by timeframe

| Timeframe | Direction |
| --- | --- |
| 15-minute | Leaning down |
| 1-hour | Down |
| 2-hour | Leaning down |
| 4-hour | Down |
| Daily | Leaning down |

## LABT order flow, momentum and trap risk

LiveChart’s Undertow, Coil and Tripwire on the 5-minute chart as of 7:55 PM ET, then the same three on the daily chart at the close.

- **Undertow (order flow)**: Hidden selling: price higher, flow lower
  - Volume: 2x this session’s norm · thin, size down
  - Flow: Price higher, volume flow lower
  - Tape: Sellers hitting through the lows
- **Coil (momentum)**: Momentum building down
  - Momentum: RSI 40 below 50, falling · expanding down
  - MACD: Below its signal, gaining
- **Tripwire (trap risk)**: Shorts graded Avoid: sitting right on support at 0.2333
  - Longs graded Clean: nothing major in the way
  - Levels: Resistance 0.2615 · support 0.2333
- **Undertow, daily chart**: Volume surge
- **Coil, daily chart**: Momentum confirms down: rSI and flow behind it
- **Tripwire, daily chart**: Shorts graded Clean: nothing major in the way

## LABT technical indicators

Daily readings at the Nov 20, 2026 close; 5-minute readings as of 7:55 PM ET.

| Indicator | Value | Reading |
| --- | --- | --- |
| RSI (14), daily | 35.8 | Below 50, rising |
| RSI (14), 5-minute | 40.4 | Below 50, falling |
| Squeeze, daily | Off | Bollinger Bands outside the Keltner Channel |
| Squeeze, 5-minute | Off | Bollinger Bands outside the Keltner Channel |
| MACD, daily | Above its signal |  |
| MACD, 5-minute | Below its signal |  |
| VWAP, last 5-minute bar | $0.2524 | Price 6.9% below |
| Fast and slow EMA, 5-minute | $0.2451 and $0.2456 | Fast under slow |
| 20-day average | $0.2896 | Price 15.4% below |
| 50-day average | $0.8024 | Price 69.5% below |
| Average daily range (ATR 14) | 53.3% | Of the price |
| Volume against its 20-day average | 1.3× | 57.67M shares |

## LABT trend history: when the daily bias turned

| Turned | Bias | Price | Held | Move while it held |
| --- | --- | --- | --- | --- |
| Jul 13, 2026 | Bearish | $2.73 | Holding, 94 sessions | −91.0% |

Past readings don’t predict future results.

## LABT daily read log

| Date | Close | Change | Stack bias | Compass | Daily RSI |
| --- | --- | --- | --- | --- | --- |
| Nov 20, 2026 | $0.2449 | +15.03% | No clear bias | 15m and 1h down | 35.8 |
| Nov 16, 2026 | $0.2194 | −22.31% | Bearish | 15m and 1h down | – |
| Nov 13, 2026 | $0.2824 | −21.38% | No clear bias | Higher timeframes down | – |

## LABT catalysts

- November 5, 2026: Lakewood-Amedex Biotherapeutics (LABT): Completion of Series C Convertible Preferred, a 182% Day (+182.4%). https://indicatorstack.com/catalysts/labt-2026-11-05-release

## LABT stock: common questions

### What are LABT’s support and resistance levels?

Measured from the Nov 20, 2026 close of $0.2449, the nearest resistance is the 20-bar high, 5-minute at $0.2615 (+6.8%) and the nearest support is the 20-bar low, 5-minute at $0.2440 (−0.4%). The full list for the next session is on this page.

### What is the technical analysis for LABT?

LABT technical analysis for Nov 20, 2026 (close $0.2449; 5-minute read as of 7:55 PM ET): LiveChart’s 5-minute stack bias has no clear direction, Compass reads “15m and 1h down” across the 15-minute to daily charts, and the daily stack bias has been bearish since Jul 13, 2026. On the daily chart, RSI (14) is 35.8, rising (below 50) and the squeeze is off. On the 5-minute chart, Undertow reads hidden selling: price higher, flow lower; Coil reads momentum building down; Tripwire has shorts graded Avoid: sitting right on support at 0.2333.

### Is LABT overbought or oversold?

At the Nov 20, 2026 close, LABT’s daily RSI (14) was 35.8, rising (below 50). On the 5-minute chart, as of 7:55 PM ET, it was 40.4, falling (below 50). Overbought here means 70 or over, oversold 30 or under; neither forecasts a turn.

### What is the trend for LABT on the 1-hour, 4-hour and daily charts?

As Compass read it at the Nov 20, 2026 close: 15-minute leaning down, 1-hour down, 2-hour leaning down, 4-hour down, Daily leaning down. Overall, Compass reads “15m and 1h down”.

### Is LABT in a squeeze?

At the Nov 20, 2026 close the squeeze (Bollinger Bands inside the Keltner Channel) was off on the daily chart and off on the 5-minute chart (as of 7:55 PM ET). Coil, LiveChart’s momentum layer, boxes every squeeze on the chart and marks its release.

### Are buyers or sellers in control of LABT?

As of 7:55 PM ET on Nov 20, 2026, Undertow, LiveChart’s order flow layer, read hidden selling: price higher, flow lower on the 5-minute chart (volume: 2x this session’s norm · thin, size down; flow: Price higher, volume flow lower; tape: Sellers hitting through the lows).

### Is LABT at risk of a bull or bear trap?

As of 7:55 PM ET on Nov 20, 2026, Tripwire, LiveChart’s trap check, had shorts graded Avoid: sitting right on support at 0.2333 on the 5-minute chart; longs graded Clean: nothing major in the way; levels: Resistance 0.2615 · support 0.2333. Its grades describe the structure around price; they aren’t a call on direction.

### What is Lakewood-Amedex Biotherapeutics’s stock price?

LABT closed at $0.2449 on Nov 20, 2026, +15.03% on the day. The chart at the top of this page shows the latest price while the market is open.

### Is LABT bullish or bearish right now?

As of the Nov 20, 2026 close the stack bias is no clear bias, with 1 of its 5 reads pointing up. On the daily chart it is bearish. Compass reads “15m and 1h down” across the 15-minute to daily timeframes. This describes the trend at the last close; it isn’t a forecast.

### Is LABT above its 50-day and 200-day moving averages?

At the Nov 20, 2026 close of $0.2449, LABT was 69.5% below its 50-day moving average ($0.8024).

### What is LABT’s 52-week high and low?

Over the past year LABT has traded between $0.1687 and $98.20, and it closed 0% of the way up that range.

### How much does LABT move in a day?

Over the last 14 sessions its average daily range (average true range) was 53.3% of its price, about $0.13 a share.

### What is LABT’s average volume?

LABT averaged 45.03M shares a day over the 20 sessions before Nov 20, 2026. That day it traded 57.67M, 1.3 times that average.

### How has LABT stock performed recently?

Measured to the Nov 20, 2026 close, LABT is down 13.3% over the past week, down 50.0% over the past month and down 88.5% over the past three months.

### Did LABT gap up on Nov 20, 2026?

Yes. It opened at $0.2322, 9.1% above the prior close of $0.2129, and closed at $0.2449 (+15.03%).

### How many shares of LABT are in the float?

About 283K shares. Traders usually count a float under 20 million shares as a low float.

### What is Lakewood-Amedex Biotherapeutics’s market cap?

About $494K, from its latest company profile. It is in the Healthcare sector (Biotechnology).

### What is the outlook for LABT stock?

This page doesn’t forecast prices. It shows where LABT stands: the stack bias is no clear bias, the nearest resistance is $0.2615, the nearest support is $0.2440, and the live chart above shows how price is reacting to those levels.

## Other Healthcare stocks

- MEDS (+84.1%): https://indicatorstack.com/chart/MEDS
- ACH (−76.7%): https://indicatorstack.com/chart/ACH
- APRE (−53.6%): https://indicatorstack.com/chart/APRE
- SNTI (−36.6%): https://indicatorstack.com/chart/SNTI
- SPRC (−34.8%): https://indicatorstack.com/chart/SPRC
- MBOT (−34.2%): https://indicatorstack.com/chart/MBOT
- PMVP (−33.1%): https://indicatorstack.com/chart/PMVP
- JAGX (−30.6%): https://indicatorstack.com/chart/JAGX
- MIST (−29.8%): https://indicatorstack.com/chart/MIST
- RNTX (−27.6%): https://indicatorstack.com/chart/RNTX

Live chart with the stack’s read on every bar: https://indicatorstack.com/chart/LABT

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
